Maze Therapeutics, Inc. Common Stock MAZE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$24.21M+26.2% | -$34.57M— | -$30.09M-21.6% | -$33.68M-124% | -$32.79M-0.9% | ||
| $444K-35.1% | $499K-29.2% | $571K-27.5% | $649K-24.0% | $684K-28.0% | ||
| $7.11M+120% | $6.07M+113% | $3.86M+64.9% | $3.24M+51.1% | $3.23M+39.7% | ||
| -$39.11M-32.5% | -$27.73M— | -$24.64M— | -$30.05M-121% | -$29.52M-25.9% | ||
| $93K-68.9% | $34K-94.4% | $68K-34.0% | $393K+146% | $299K+7.2% | ||
| $6.28M+2,199% | -$103.39M-16,989% | -$66.88M-64,835% | -$393K-146% | -$299K-7.2% | ||
| $39.4M— | —— | —— | —— | —— | ||
| $42.36M-66.7% | $3.59M-94.9% | $143.76M— | $612K+297% | $127.38M+418% | ||
| $9.52M-90.2% | -$127.53M-370% | $52.23M— | -$29.83M-121% | $97.56M+11,179% | ||
| -$39.21M-31.5% | -$27.76M— | -$24.71M— | -$30.45M-121% | -$29.82M-25.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maze Therapeutics, Inc. Common Stock generate?
- Maze Therapeutics, Inc. Common Stock (MAZE) generated -$121.5M in operating cash flow over the trailing twelve months.
- What is Maze Therapeutics, Inc. Common Stock's free cash flow?
- After $588.0K of capital expenditures, Maze Therapeutics, Inc. Common Stock's free cash flow was -$122.1M over the trailing twelve months.
- Where does Maze Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Maze Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
